- Home
- FWRG vs VALN Comparison
FWRG vs VALN Comparison
Compare FWRG & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FWRG
- VALN
- Stock Information
- Founded
- FWRG 1983
- VALN 2012
- Country
- FWRG United States
- VALN France
- Employees
- FWRG N/A
- VALN N/A
- Industry
- FWRG Restaurants
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FWRG Consumer Discretionary
- VALN Health Care
- Exchange
- FWRG Nasdaq
- VALN Nasdaq
- Market Cap
- FWRG 970.4M
- VALN 989.8M
- IPO Year
- FWRG 2021
- VALN 2021
- Fundamental
- Price
- FWRG $18.59
- VALN $8.65
- Analyst Decision
- FWRG Strong Buy
- VALN Strong Buy
- Analyst Count
- FWRG 10
- VALN 4
- Target Price
- FWRG $22.20
- VALN $16.00
- AVG Volume (30 Days)
- FWRG 915.7K
- VALN 153.0K
- Earning Date
- FWRG 08-05-2025
- VALN 08-12-2025
- Dividend Yield
- FWRG N/A
- VALN N/A
- EPS Growth
- FWRG N/A
- VALN N/A
- EPS
- FWRG 0.06
- VALN N/A
- Revenue
- FWRG $1,105,027,000.00
- VALN $230,566,060.00
- Revenue This Year
- FWRG $22.06
- VALN $15.55
- Revenue Next Year
- FWRG $16.21
- VALN $23.93
- P/E Ratio
- FWRG $317.53
- VALN N/A
- Revenue Growth
- FWRG 14.53
- VALN 25.47
- 52 Week Low
- FWRG $12.90
- VALN $3.62
- 52 Week High
- FWRG $22.71
- VALN $12.25
- Technical
- Relative Strength Index (RSI)
- FWRG 56.44
- VALN 46.30
- Support Level
- FWRG $18.27
- VALN $8.05
- Resistance Level
- FWRG $19.39
- VALN $9.11
- Average True Range (ATR)
- FWRG 0.63
- VALN 0.40
- MACD
- FWRG -0.00
- VALN -0.33
- Stochastic Oscillator
- FWRG 62.99
- VALN 14.22
About FWRG First Watch Restaurant Group Inc.
First Watch Restaurant Group Inc is a daytime restaurant concept serving made-to-order breakfast, brunch, and lunch using fresh ingredients. It generates revenues from Restaurant sales and Franchise revenues.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.